REDD1 and Related Molecular Mechanism of Zoledronic Acid-treated Human Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions
碩士 === 國立陽明大學 === 藥理學研究所 === 100 === Zoledronic acid (ZOL) is a bisphosphonate used to prevent/treat skeletal complications in breast cancer patients with bone metastasis. Previous study has found that ZOL inhibited growth and mTOR expression in breast cancer cells. REDD1 is a regulator of DNA damag...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2012
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/96953886182507434614 |